In 2015 DJS Antibodies founded upon a vision of creating the next generation of antibody therapeutics. We developed HEPTAD, a revolutionary platform for antibody discovery, and now use this to create novel therapeutics that will have a meaningful impact on the lives of patients.
to deliver revolutionary
A world where safe, efficacious therapeutics improve the lives of people with chronic inflammatory diseases
What we do
Building a pipeline of unique assets enabled by a world-leading platform for antibody discovery
takes great people
We believe that creating a culture of scientific excellence is the best way to make a meaningful difference to patients’ lives. There are brilliant people behind every medical breakthrough and our team is passionate about delivering scientific innovation to make tomorrow’s breakthroughs a reality.
The latest news and insights from DJS
If you're looking to be surrounded by fantastic people and join an exciting team working on the cutting edge of drug discovery, get in touch!